总时间（秒）：21.03
问答时间（秒）：20.99

```json
{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_000177546.4:c.6147G>A",
          "cDNA Change": {
            "transcript": "NM_000177546.4",
            "ref": "G",
            "alt": "A",
            "position": "6147"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "2049"
          },
          "Description in input context": "This variant alters a critical kinase domain residue."
        },
        {
          "HGVS": "NM_000177546.4:c.8788T>G",
          "cDNA Change": {
            "transcript": "NM_000177546.4",
            "ref": "T",
            "alt": "G",
            "position": "8788"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "G",
            "position": "2929"
          },
          "Description in input context": "This variant resides in the Ras GTPase-activating protein (GAP) domain."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003820"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro kinase assay",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant LRRK2 kinase domain",
        "Description": "The experiment used the recombinant LRRK2 kinase domain."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000177546.4:c.6147G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced kinase activity",
          "Result Description": "The variant c.6147G>A resulted in a ~50% reduction in phosphorylation activity compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_000177546.4:c.8788T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered substrate specificity",
          "Result Description": "The variant c.8788T>G demonstrated an altered substrate specificity compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were performed in triplicate for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N/A"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "A kinase dead mutant was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to compare activity between samples."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation activity greater than 80% of baseline.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation activity less than 50% of baseline.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```